“Targeting Alpha-Synuclein As a Treatment for Parkinson’s Disease ”. International Journal of Pharmaceutical and Healthcare Innovation, vol. 1, no. 04, Aug. 2024, pp. 296-07, https://doi.org/10.62752/9v9h6s45.